产品编号：V758200
产品规格：50mg
产品价格：面议
| 标准品编号: | V758200 |
| 名称: | Vorapaxar Sulfate |
| 别名: | N-[(1R,3aR,4aR,6R,8aR,9S,9aS)-9-[(1E)-2-[5-(3-Fluorophenyl)-2-pyridinyl]ethenyl]dodecahydro-1-methyl-3-oxonaphtho[2,3-c]furan-6-yl]carbamic Acid Ethyl Ester Sulfate; Sch 530348; |
| CAS号: | 705260-08-8 |
| 参考CAS号: | 618385-01-6-free base |
| 分子式: | C₂₉H₃₅FN₂O₈S |
| 外观: | 白色固体 |
| 熔点: | >199ºC (dec.) |
| 分子量: | 590.66 |
| 储存: | Hygroscopic, 冰箱, under inert atmosphere |
| 溶解度: | Acetonitrile (Very Slightly, Heated), Methanol (Slightly) |
| 类别: | Standards; Chiral Molecules; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients. |
| 参考文献 | |
